Filing Details

Accession Number:
0001209191-15-070366
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-11 17:28:51
Reporting Period:
2015-09-11
Filing Date:
2015-09-11
Accepted Time:
2015-09-11 17:28:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1469443 Arcadia Biosciences Inc. RKDA Agricultural Chemicals (2870) 810571538
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1640691 Zhongjin Lu C/O Arcadia Biosciences, Inc.
202 Cousteau Place, Suite 105
Davis CA 95618
Vp Product Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-09-11 2,958 $0.44 15,828 No 4 M Direct
Common Stock Disposition 2015-09-11 1,068 $4.92 14,760 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2015-09-11 2,958 $0.00 2,958 $0.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-12-31 No 4 M Direct
Footnotes
  1. The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan (the "Plan"), adopted by the Reporting Person on June 14, 2015. Pursuant to the Plan and in compliance with the Issuer's IPO Lock-up Agreements with Credit Suisse Securities (USA) ("CSSU"), the Reporting Person paid the exercise price and CSSU sold shares only to satisfy the tax liability and costs. The balance of the shares will be held until the expiration of the IPO Lock-up Agreements.
  2. This transaction was executed in multiple trades at prices ranging from $4.79 to $5.11. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. The option is fully exercisable as of the date hereof.